Euy S. Moon
Mainz, RP, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 35 publications
A true theranostic pair - 44/47Sc-labeled GRPR antagonist shows great promise for managing prostate and breast cancer.
Journal: European journal of nuclear medicine and molecular imaging
Published: September 05, 2025
Long-Term Outcomes in Radioiodine-Resistant Follicular Cell-Derived Thyroid Cancers Treated with [177Lu]Lu-DOTAGA.FAPi Dimer Therapy.
Journal: Thyroid : official journal of the American Thyroid Association
Published: January 27, 2025
Biodistribution and Dosimetry Evaluation of the Radiolabeled Somatostatin Receptor Antagonist 68 Ga-DATA 5m LM4 in Molecular Imaging of Well-Differentiated Gastroenteropancreatic Neuroendocrine Tumors Patients.
Journal: Clinical nuclear medicine
Published: January 06, 2025
Exploring currently available fibroblast activation protein targeting molecules in adrenocortical carcinoma: Navigating theranostic pathways.
Journal: European journal of nuclear medicine and molecular imaging
Published: January 05, 2025
Exploring the FAP-Targeted Therapeutics for Adrenocortical Carcinoma: Choosing the Right Track.
Journal: Clinical nuclear medicine
Published: November 06, 2024
Improved FAPI-radiopharmaceutical pharmacokinetics from the perspectives of a dose escalation study.
Improved FAPI-radiopharmaceutical pharmacokinetics from the perspectives of a dose escalation study.
Journal: European journal of nuclear medicine and molecular imaging
Published: November 01, 2024
68 Ga-DOTA.SA.FAPi PET in Response Assessment After 177 Lu-Microspheres Selective Intra-arterial Radionuclide Therapy for Unresectable Hepatocellular Carcinoma.
Journal: Clinical nuclear medicine
Published: August 01, 2024
Tailoring Fibroblast-Activation Protein Targeting for Theranostics: A Comparative Preclinical Evaluation of the 68Ga- and 177Lu-Labeled Monomeric and Dimeric Fibroblast-Activation Protein Inhibitors DOTA.SA.FAPi and DOTAGA.(SA.FAPi)2.
Journal: Molecules (Basel, Switzerland)
Published: May 17, 2024
Druglike, 18F-labeled PET Tracers Targeting Fibroblast Activation Protein.
Journal: Journal of medicinal chemistry
Published: April 24, 2024
Head-to-Head Comparison of SSTR Antagonist [68Ga]Ga-DATA5m-LM4 with SSTR Agonist [68Ga]Ga-DOTANOC PET/CT in Patients with Well Differentiated Gastroenteropancreatic Neuroendocrine Tumors: A Prospective Imaging Study.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: January 07, 2024
68Ga-DOTA.SA.FAPi as a Versatile Diagnostic Probe for Various Epithelial Malignancies: A Head-to-Head Comparison with 18F-FDG.
Journal: Academic radiology
Published: August 02, 2023
Therapeutic potential of [177Lu]Lu-DOTAGA-FAPi dimers in metastatic breast cancer patients with limited treatment options: efficacy and safety assessment.
Journal: European journal of nuclear medicine and molecular imaging
Published: July 16, 2023
Last Updated: 09/26/2026